Peptide questions · Eloralintide

How long does eloralintide take to work?

Reviewed Evidence: ModeratePublished by PepVault

Eloralintide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 2 endpoint), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 1 (Bhattachar 2026), phase 2 RCT (Billings 2025, Lancet; NCT06230523 posted results), Lilly releases Nov-6-2025, Sep-30-2026 and Nov-14-2026. Investigational.

Eloralintide week by week

The library places six of its research notes on eloralintide on the days they cover, from day 1 to day 336 and on: 4 on randomized trials and 2 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The eloralintide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Fullness first, gentlyRandomized trial
Days 29–56 (weeks 5–8)The step where nausea shows upRandomized trial
Days 57–336 (weeks 9–48)Holding at 6 mgRandomized trial
Days 57–336 (weeks 9–48)The top dose testedRandomized trial
Days 85–336 (weeks 13–48)Fewer cravings, quieter food noiseClinical data
From day 337 onA long-term medicine, not a courseClinical data
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track eloralintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The eloralintide timeline’s milestones

The library’s timeline for eloralintide marks 5 points from week 1 to week 48, backed by moderate evidence overall.

  • Week 1: Commonly reported: feeling full sooner at meals, with nausea more likely on the higher doses
  • Week 4: The phase 2 step-up arm moved from 3 mg to 6 mg after 4 weeks
  • Week 8: The same arm moved to 9 mg from week 9
  • Week 12: In phase 1, people on 12 mg had lost about 11% more than placebo by week 12
  • Week 48: Phase 2 endpoint: about 9.5% (1 mg) to 20% (9 mg) average loss vs 0.4% on placebo

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why eloralintide takes that long

Eloralintide’s half-life is about 14 days (336 hours), so one dose is about 96.9% cleared after 70 days.

On its schedule (Weekly) the doses overlap, and the level of eloralintide keeps climbing for about 56–70 days before it levels off, so the first 56–70 days run below the level the later weeks hold.

The notes on eloralintide follow the trials’ dose steps, 3mg, 6mg and 9mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Eloralintide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, eloralintide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does eloralintide take to work?

Eloralintide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 2 endpoint), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does eloralintide reach its peak effect?

By the library’s timeline, eloralintide’s peak effect comes at 48 weeks (phase 2 endpoint), backed by moderate evidence.

How long is eloralintide usually run?

The library’s timeline gives eloralintide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 12 weeks in phase 1 and 48 weeks in phase 2; phase 3 runs about 75 weeks.

What does the library say about the first days on eloralintide?

Its first note on eloralintide, for days 1–28 (weeks 1–4), is “Fullness first, gently”, resting on randomized trials.

More on eloralintide

Track it in the app

PepVault for iPhone

Track eloralintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo